We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
-21.49%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$86M
Cap. Flow
+$2.98M
Cap. Flow %
1.17%
Top 10 Hldgs %
85.68%
Holding
22
New
2
Increased
–
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
QSI icon
Quantum-Si Incorporated
QSI
+$24.5M
2
ME
23andMe Holding Co
ME
+$7.28M

Top Sells

Rank Stock Value
1
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
+$7.2M
2
PHVS icon
Pharvaris
PHVS
+$6.81M
3
ALXO icon
ALX Oncology
ALXO
+$5.31M
4
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
+$4.06M
5
PNT
POINT Biopharma Global Inc. Common Stock
PNT
+$3.68M

Sector Composition

Rank Sector Weight
1 Healthcare 94.17%
2 Financials 1.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEM icon
1
Cullinan Oncology
CGEM
$1.05B
$70.3M 27.67%
2,731,410
– –
QSI icon
2
Quantum-Si Incorporated
QSI
$168M
$28.7M 11.3%
+2,342,061
New +$24.5M
ACRS icon
3
Aclaris Therapeutics
ACRS
$730M
$22.1M 8.69%
1,258,243
– –
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$20.4M 8.01%
875,001
– –
IRON icon
5
Disc Medicine
IRON
$2.83B
$15.8M 6.2%
81,171
– –
RLAY icon
6
Relay Therapeutics
RLAY
$4.02B
$14.6M 5.76%
400,000
– –
ALXO icon
7
ALX Oncology
ALXO
$273M
$12.6M 4.97%
231,200
-88,800
-28% -$5.31M
NRIX icon
8
Nurix Therapeutics
NRIX
$2.43B
$12M 4.71%
451,522
– –
HIMS icon
9
Hims & Hers Health
HIMS
$6.5B
$11.5M 4.53%
1,056,922
– –
PHICU
10
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
$9.74M 3.83%
960,000
– –
ME
11
DELISTED
23andMe Holding Co
ME
$8.18M 3.22%
+35,000
New +$7.28M
PHVS icon
12
Pharvaris
PHVS
$2.39B
$6.78M 2.67%
364,142
-300,000
-45% -$6.81M
PRDS
13
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$6.01M 2.37%
602,500
– –
RACB
14
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$5.07M 1.99%
500,000
– –
TNGX icon
15
Tango Therapeutics
TNGX
$4.34B
$4.55M 1.79%
400,000
– –
LHDX
16
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$3.22M 1.27%
485,000
– –
MLTX icon
17
MoonLake Immunotherapeutics
MLTX
$1.59B
$2.59M 1.02%
250,000
– –
IMVT icon
18
Immunovant
IMVT
$8.09B
– –
-50,000
Closed -$802K
OLK
19
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
– –
-200,000
Closed -$7.2M
SNCE
20
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
– –
-20,000
Closed -$4.06M
PNT
21
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-350,000
Closed -$3.68M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
PFG
Prosperity Financial Group San Ramon, California $271M AUM 30.27% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
ACH
Axis Capital Holdings Pembroke, Bermuda $270M AUM 16.26% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return

Foresite Capital Management V's Q2 2021 Portfolio in Review

As of Q2 2021, Foresite Capital Management V held 22 positions worth $254M, down 25% from $340M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Foresite Capital Management V's Q2 2021 filing shows 2 new, 2 reduced and 5 closed positions. Its largest new stake was Quantum-Si Incorporated: 2,342,061 shares worth $28.7M. The largest sale was Olink Holding AB (publ) American Depositary Shares, an estimated $7.2M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Financials.

  • Foresite Capital Management V's largest Q2 2021 buy was Quantum-Si Incorporated: 2,342,061 shares worth $28.7M.
  • Foresite Capital Management V's biggest Q2 2021 reduction was Pharvaris, cutting an estimated $6.81M.
  • Foresite Capital Management V fully exited Olink Holding AB (publ) American Depositary Shares in Q2 2021, selling an estimated $7.2M.
  • Foresite Capital Management V's ten largest holdings make up 86% of its $254M portfolio in Q2 2021.
  • Foresite Capital Management V opened 2 new positions and closed 5 in Q2 2021.
  • Foresite Capital Management V's portfolio value fell 25% quarter-over-quarter to $254M.

Based on Foresite Capital Management V's 13F filing for Q2 2021, filed 16 Aug 2021.